Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
CanSino Biologics Catalyst Calendar
Proactively evaluate CanSino Biologics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of CanSino Biologics Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Aug 2020 | Phase III Trial Initiation | Beijing Institute of Biotechnology; Bill & Melinda Gates Foundation; Canadian Center for Vaccinology; CanSino Biologics Inc; Dalhousie University; Hangzhou Tigermed Consulting Co Ltd; IWK Health Centre; Ministry of Health, Saudi Arabia | 300347; 6185 | COVID-19 [adenovirus type 5] Vaccine | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Clinical Trial Registry |
| 04 May 2020 | Phase I Trial Initiation | CanSino Biologics Inc; Henan Province Disease Prevention and Control Center; Tianjin University of Science and Technology | 6185 | pneumococcal (13-valent) vaccine | Infectious Disease | Streptococcal Infections; Unspecified Bacterial Infections | Clinical Trial Registry |
| 30 Apr 2020 | Phase I Trial Initiation | CanSino Biologics Inc; Henan Province Disease Prevention and Control Center | 6185 | (diphtheria + pertussis (acellular) + tetanus) vaccine | Infectious Disease | Diphtheria; Pertussis (Whooping Cough); Tetanus | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer